Bibliography
-
F. B. Peairs, “Bt Corn: Health and the Environment,” Production, no. 0.707 (Colorado State University Extension, August 2010). Alejandro E. Segarra and Jean M. Rawson, “StarLink Corn Controversy: Background,” CRS Report for Congress, updated January 10, 2001.
-
Alejandro E. Segarra and Jean M. Rawson, “StarLink Corn Controversy: Background,” CRS Report for Congress, updated January 10, 2001.
-
Mark K. Sears, Richard L. Hellmich, Diane E. Stanley-Horn, Karen S. Oberhauser, John M. Pleasants, Heather R. Mattila, Blair D. Siegfried, and Galen P. Dively, “Impact of Bt corn pollen on monarch butterfly populations: A risk assessment,” Proceedings of the National Academy of Sciences, vol. 98, no. 21 (October 9, 2001), pp. 11937–11942.
-
David Liénard, Christophe Sourrouille, Véronique Gomord, and Loic Faye, “Pharming and transgenic plants,” Biotechnology Annual Review, vol. 13 (2007), pp. 115-147.
-
Abdoreza Davoodi-Semiromi, Natapalli Samson, and Henry Daniell, “The green vaccine: A global strategy to combat infectious and autoimmune diseases,” Human Vaccines, vol. 5, no. 7 (July 2009), pp. 448-493.
-
Center for Science in the Public Interest, “The Future of Pharming: Can It Be Done Safely?” Roundtable Discussion, December 17, 2002. Natasha Gilbert, “Fees delayed pharmed drug,” Nature, vol. 458, no. 951 (2009). National Research Council, Animal Biotechnology: Science Based Concerns (Washington, DC: National Academies Press, 2002), p. 12.
-
Union of Concerned Scientists, “Position Paper: Pharmaceutical and Industrial Crops,” (October 2006), pp 1-23
-
Pal, K. K. and B. McSpadden Gardener, 2006. “Biological Control of Plant Pathogens.” The Plant Health Instructor, 2006, pp1-25.
-
Greg Jaffe, “Questions About Genetically Engineered Animals,” Miami Herald, October 23
-
Gregory Jaffe, “Regulatory slowdown on GM crop decisions,” Nature Biotechnology, vol. 24, no. 7 (July 2006), pp. 7480749.
-
Federation of Animal Science Societies, “Guide for the Care and Use of Agricultural Animals in Research and Teaching,” (January 2010), pp1-160
-
Center for Science in the Public Interest, “How Should the Next Administration Address Genetically Engineered Food Animals?” Greg Jaffe, “Questions About Genetically Engineered Animals,” Miami Herald, October 23, 2008.
-
ActionBioscience.org, “Transgenic Animals: Their Benefits to Human Welfare.”
-
University of Guelph, EnviropigTM http://www.uoguelph.ca/enviropig/technology.shtml
-
Gregory Jaffe, “Genetically Engineered Salmon – Healthy for You, But is it Healthy for the Earth?” FDLI Update (Washington, DC: Food and Drug Law Institute), November/December 2010, p. 34.
-
Yann Echelard, Carol A. Ziomek, and Harry M. Meade, “Production of recombinant therapeutic proteins in the milk of transgenic animals,” BioPharm International.com, August 1, 2008.
-
Echelard, Ziomek, and Meade, “Production of Recombinant Therapeutic Proteins.”, http://biopharminternational.findpharma.com/biopharm/Article/Production-of-Recombinant-Therapeutic-Proteins-in-/ArticleStandard/Article/detail/362005
-
Lois Rogers, “Hop over here, Flopsy Bunny, stroke victims need your milk,” London Sunday Times, January 17, 2010. Heiner Niemann and Wilfried A. Kues, “Transgenic farm animals: an update,” Reproduction, Fertility and Development, vol. 19, no. 6 (August 2, 2007), pp. 762-770. Jim Kling, “First US approval for a transgenic animal drug,” Nature Biotechnology, vol. 27 (2009), pp. 302-304
-
ActionBioscience.org, “Transgenic Animals”; David Gillespie, “Pharming for Farmaceuticals,” Department of Genetics, University of Utah, http://www.learn.genetics.utah.edu
-
Emanuele Cozzi and David J.G. White, “The generation of transgenic pigs as potential organ donors for humans,” Nature Medicine, vol. 1, no. 9 (September 1995), pp. 964-966.
-
Robin A Weiss, “The discovery of endogenous retroviruses”, Retrovirology (October 2006) http://www.retrovirology.com/content/3/1/67